Oral administration of synthetic retinoid Am80 inhibits the development of type 1 diabetes in non-obese diabetic (NOD) mice

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 1, 2009, Pages 157-159

  Miwako, Ishido ^a   Shudo, Koichi ^a  

^a Kawasaki   (Japan)

Author keywords

Am80; Non obese diabetic mouse; Retinoid; Type 1 diabetes

Indexed keywords

GLUCOSE; RETINOID; TAMIBAROTENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; FEMALE; GLUCOSE URINE LEVEL; HISTOPATHOLOGY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; SUBMANDIBULAR GLAND;

ADMINISTRATION, ORAL; ANIMALS; BENZOATES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCOSURIA; MICE; MICE, INBRED NOD; PANCREAS; RECOMBINANT PROTEINS; RETINOIDS; SALIVARY GLANDS; SURVIVAL ANALYSIS; TETRAHYDRONAPHTHALENES;

EID: 59949095296     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.157     Document Type: Article

References (17)

1. Eisenbarth G. S., Adv. Exp. Med. Biol., 552, 306-310 (2004).
2. Yang Y., Santamaria P., Clin. Sci. (London), 110, 627-639 (2006).
3. Beehler B. C., Brinckerhoff C. E., Ostrowski J., Curr. Opin. Investig. Drugs, 5, 1153-1157 (2004).
4. Hayes C. E., Nashold F. E., Gomez F. E., Hoag K. A., "Retinoids: The Biochemical and Molecular Basis of Vitamin A and Retinoid Action," ed. by Nau H., Blaner W. S., Springer-Verlag, New York, 1999, pp. 589-610.
5. Iwata M., Eshima Y., Kagechika H., Int. Immunol., 15, 1017-1025 (2003).
6. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., Cheroutre H., Science, 317, 256-260 (2007).
7. Elias K. M., Laurence A., Davidson T. S., Stephens G., Kanno Y., Shevach E. M., O'Shea J. J., Blood, 111, 1013-1020 (2008).
8. Fukasawa H., Iijima T., Kagechika H., Hashimoto Y., Shudo K., Biol. Pharm. Bull., 16, 343-348 (1993).
9. Nagai H., Matsuura S., Bouda K., Takaoka Y., Wang T., Niwa S., Shudo K., Pharmacology, 58, 101-112 (1999).
10. Kuwabara K., Shudo K., Hori Y., FEBS Lett., 378, 153-156 (1996).
11. Niwa S., Ochi T., Hirano Y., Wang T., Inagaki N., Shudo K., Nagai H., Pharmacology, 60, 208-214 (2000).
12. Wang T., Niwa S., Bouda K., Matsuura S., Homma T., Shudo K., Nagai H., Life Sci., 67, 1869-1879 (2000).
13. Kagechika H., Kawachi E., Hashimoto Y., Shudo K., Chem. Pharm. Bull., 32, 4209-4212 (1984).
14. Wong F. S., Wen L., Tang M., Ramanathan M., Visintin I., Daugherty J., Hannum L. G., Janeway C. A. Jr., Shlomchik M. J., Diabetes, 53, 2581-2587 (2004).
15. Zunino S. J., Storms D. H., Stephensen C. B., J. Nutr., 137, 1216-1221 (2007).
16. Devulder B., Plouvier B., Wattre P., Tacquet A., Ferrando R., Int. J. Vitam. Nutr. Res., 46, 322-329 (1976).
17. This paper was presented at the 17th Annual Meeting for Japanese Society for Retinoid Research, Tokyo, on 4 November 2006.